WILMINGTON, DE — Enovis™ Corporation has announced that Chief Executive Officer Matt Trerotola will retire once the Board of Directors appoints his successor. The company is actively working with an executive search firm to identify a MedTech leader focused on growth and innovation to step into the role.
To ensure a seamless transition, Trerotola has agreed to serve as an Executive Advisor for one year after his successor assumes the position. “Working with the exceptionally talented team at Enovis has been a great honor,” said Trerotola. “Today, Enovis is a global company well-positioned for continued growth thanks to our high-quality portfolio, focus on continuous improvement, and exceptional team. Given the Company’s strong position, now is the right time to plan the transition to our next leader.”
Sharon Wienbar, Lead Independent Director of Enovis, praised Trerotola’s contributions, stating, “Matt has been instrumental in driving Enovis’ transformation into a leading global MedTech innovator. He has played a pivotal role in shaping the Company, fostering innovation, and building a culture of excellence. The Board remains committed to appointing a CEO who shares our commitment to innovative solutions that improve patient outcomes.”
Enovis stands poised for its next chapter of leadership while remaining focused on its mission of delivering industry-leading growth and innovation in MedTech.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.